| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.01 |
1 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.0017 |
1 |